| 23/07/26 | 11:11:00 | 23 Jul 2026 | | Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing | GNW |
| 28/04/26 | 07:00:00 | 28 Apr 2026 | | Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study | GNW |
| 02/09/24 | 07:00:09 | 2 Sept 2024 | | Scancell to attend upcoming conferences | RNS |
| 30/07/24 | 07:17:22 | 30 Jul 2024 | | Scancell Appoints Dr Nermeen Varawalla as CMO | RNS |
| 30/07/24 | 07:00:10 | 30 Jul 2024 | | Scancell Appoints Dr Nermeen Varawalla as CMO | RNS |
| 24/07/24 | 07:00:04 | 24 Jul 2024 | | Update from iSCIB1+ Clinical Advisory Meeting | RNS |
| 10/07/24 | 07:00:09 | 10 Jul 2024 | | Appointment of Dr Florian Reinaud to the Board | RNS |
| 02/07/24 | 07:00:10 | 2 Jul 2024 | | Extension of Convertible Loan Notes | RNS |
| 01/07/24 | 07:00:06 | 1 Jul 2024 | | Block Listing Return and Total Voting Rights | RNS |
| 21/06/24 | 07:00:12 | 21 Jun 2024 | | Change of Nominated Advisor | RNS |
| 12/06/24 | 07:32:29 | 12 Jun 2024 | | Agreement with major biotech | RNS |
| 31/05/24 | 07:00:08 | 31 May 2024 | | Scancell to attend upcoming conferences | RNS |
| 30/05/24 | 07:00:11 | 30 May 2024 | | Update on ModiFY trial | RNS |
| 24/05/24 | 07:00:06 | 24 May 2024 | | Scancell to present at ASCO Annual Meeting | RNS |
| 21/05/24 | 07:00:11 | 21 May 2024 | | Issue of share options | RNS |
| 16/05/24 | 07:00:04 | 16 May 2024 | | Presenting at the Sachs 10th Annual Oncology Forum | RNS |
| 09/05/24 | 07:00:09 | 9 May 2024 | | Scancell presenting at 21st CIMT Annual Meeting | RNS |
| 17/04/24 | 07:00:07 | 17 Apr 2024 | | Presenting at the Annual Immuno-Oncology Summit | RNS |
| 16/04/24 | 07:00:12 | 16 Apr 2024 | | Block Listing Six Monthly Return | RNS |
| 03/04/24 | 07:00:06 | 3 Apr 2024 | | Employee exercise of share options | RNS |
| 02/04/24 | 07:00:09 | 2 Apr 2024 | | Scancell to Present at 2024 AACR Annual Meeting | RNS |
| 28/03/24 | 13:21:18 | 28 Mar 2024 | | Scancell Appoints WG as Joint Broker | RNS |
| 26/03/24 | 12:22:55 | 26 Mar 2024 | | First iSCIB1+ patient dosed | RNS |
| 14/03/24 | 11:17:05 | 14 Mar 2024 | | Appointment of Sath Nirmalananthan to the Board | RNS |
| 12/03/24 | 07:00:10 | 12 Mar 2024 | | Scancell Attendance at Upcoming Conferences | RNS |
| 04/03/24 | 07:00:06 | 4 Mar 2024 | | Presenting at Next-Gen Immuno-Oncology Conference | RNS |
| 20/02/24 | 07:00:07 | 20 Feb 2024 | | Change of Auditor | RNS |
| 05/02/24 | 07:00:11 | 5 Feb 2024 | | Directorate Change | RNS |
| 30/01/24 | 07:00:06 | 30 Jan 2024 | | Interim Results | RNS |
| 26/01/24 | 07:00:07 | 26 Jan 2024 | | Notice of Interim Results and Presentation | RNS |
| 17/01/24 | 13:46:09 | 17 Jan 2024 | | Update on SCOPE trial | RNS |
| 28/12/23 | 17:36:53 | 28 Dec 2023 | | Holding(s) in Company | RNS |
| 27/12/23 | 11:38:01 | 27 Dec 2023 | | Holding(s) in Company | RNS |
| 19/12/23 | 07:00:12 | 19 Dec 2023 | | Result of the Open Offer | RNS |
| 06/12/23 | 12:41:41 | 6 Dec 2023 | | PDMR Notification | RNS |
| 01/12/23 | 07:00:10 | 1 Dec 2023 | | Results of Placing | RNS |
| 30/11/23 | 17:03:37 | 30 Nov 2023 | | Proposed Capital Raise to raise approximately £6m | RNS |
| 29/11/23 | 14:35:28 | 29 Nov 2023 | | Result of AGM | RNS |
| 28/11/23 | 07:00:11 | 28 Nov 2023 | | Update on SCOPE trial | RNS |
| 10/11/23 | 08:32:50 | 10 Nov 2023 | | Scancell to present at 20th SMR Congress | RNS |
| 01/11/23 | 07:00:10 | 1 Nov 2023 | | Scancell to present at 38th Annual SITC meeting | RNS |
| 31/10/23 | 12:00:00 | 31 Oct 2023 | | Notice of AGM | RNS |
| 31/10/23 | 07:00:12 | 31 Oct 2023 | | Results for the Year Ended 30 April 2023 | RNS |
| 20/10/23 | 07:00:07 | 20 Oct 2023 | | Update on Final Results | RNS |
| 18/10/23 | 07:00:08 | 18 Oct 2023 | | Scancell to speak at World Vaccine Congress Europe | RNS |
| 17/10/23 | 07:00:11 | 17 Oct 2023 | | Block Listing Six Monthly Return | RNS |
| 11/10/23 | 07:00:13 | 11 Oct 2023 | | Change of Date for Final Results | RNS |
| 03/10/23 | 07:00:09 | 3 Oct 2023 | | Notice of Final Results and Investor Presentation | RNS |
| 19/09/23 | 07:00:05 | 19 Sept 2023 | | Positive data from Phase 2 SCOPE trial with SCIB1 | RNS |
| 14/09/23 | 07:00:04 | 14 Sept 2023 | | Scancell to present three posters at ICI | RNS |
